drugset / Trial / NCT02802072

Enterprise Stent Implantation in the Treatment of Carotid Artery Stenosis With Ischemic Stroke

NCT02802072

Completed 100 enrolled Beijing Chao Yang Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the long-term effects of intracranial implantation of Enterprise stent system versus antiplatelet medication on neurologic deficits, daily living abilities, and carotid artery stenosis in patients with atherosclerotic ischemic stroke.

Timeline

Start
2013-01
Primary completion
2014-01
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 100 mg

Indications